In clear cell Renal Cell Carcinoma (ccRCC), Y-box binding protein 1 (YB1) mediated upregulation of EphA2 by reducing its proteasomal degradation and this strongly correlated with resistance to sunitinib and acquisition of invasive properties. Here, YBX1 is linked to nonpapillary renal cell carcinoma.